04:41 PM EST, 11/03/2025 (MT Newswires) -- Exact Sciences ( EXAS ) reported Q3 adjusted net income late Monday of $0.24 per diluted share, up from $0.07 a year earlier.

Analysts polled by FactSet expected $0.15.

Revenue in the three months ended Sept. 30 rose to $850.7 million from $708.7 million a year earlier.

Analysts polled by FactSet expected $810.5 million.

The company raised 2025 revenue guidance to the range of $3.22 billion to $3.235 billion from $3.13 billion to $3.17 billion.

Analysts polled by FactSet project $3.16 billion.

The company's shares rose 6.8% in after-hours trading.